NMTR RSI Chart
Last 7 days
100%
Last 90 days
-97.0%
Trailing 12 Months
-99.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 374.6K | 0 | 0 | 0 |
2022 | 30.4K | 89.2K | 219.5K | 0 |
2021 | 19.9K | 20.8K | 21.8K | 22.7K |
2020 | 169.8K | 151.9K | 82.5K | 19.0K |
2019 | 173.6K | 183.4K | 193.2K | 0 |
2018 | 0 | 0 | 1.0M | 163.8K |
2017 | 4.5M | 3.0M | 2.3M | 1.9M |
2016 | 7.4M | 7.8M | 4.4M | 4.1M |
2015 | 0 | 10.3M | 9.3M | 8.3M |
2014 | 0 | 0 | 0 | 11.3M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 21, 2023 | sensenig bethany | sold | -11,011 | 1.21 | -9,100 | chief financial officer |
Mar 29, 2023 | johnson lorin k | acquired | - | - | 7,885 | - |
Mar 29, 2023 | rice yehuda michael | acquired | - | - | 7,885 | - |
Mar 29, 2023 | ventimiglia samantha | acquired | - | - | 7,885 | - |
Mar 29, 2023 | sirgo mark a | acquired | - | - | 7,885 | - |
Mar 29, 2023 | constantino michael t. | acquired | - | - | 7,885 | - |
Mar 27, 2023 | sensenig bethany | acquired | - | - | 50,177 | chief financial officer |
Mar 27, 2023 | temperato john | acquired | - | - | 68,815 | chief executive officer |
Jul 06, 2022 | temperato john | bought | 28,462 | 0.2277 | 125,000 | chief executive officer |
Jul 01, 2022 | sirgo mark a | bought | 42,962 | 0.2455 | 175,000 | - |
Which funds bought or sold NMTR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Feb 13, 2024 | Strategic Investment Solutions, Inc. /IL | reduced | -98.41 | -2,284 | - | -% |
Feb 14, 2023 | Axiom Investment Management LLC | sold off | -100 | - | - | -% |
Nov 14, 2022 | REGENTATLANTIC CAPITAL LLC | sold off | -100 | -11,000 | - | -% |
Nov 10, 2022 | Ashfield Capital Partners, LLC | unchanged | - | -2,000 | 7,000 | -% |
Oct 26, 2022 | WIPFLI FINANCIAL ADVISORS LLC, | new | - | 1,000 | 1,000 | -% |
Aug 15, 2022 | Frontier Wealth Management LLC | unchanged | - | -7,000 | 8,000 | -% |
May 16, 2022 | Amalgamated Financial Corp. | new | - | 22,000 | 22,000 | -% |
Unveiling 9 Meters Biopharma Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
9 Meters Biopharma Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q1 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 |
Revenue | 25.2% | 164,787 | 131,655 | 65,319 | 12,814 | 9,718 | 1,397 | 6,505 | 5,087 | 4,191 | 3,295 | 8,550 | 12,815 | 57,848 | 72,641 | 26,456 | 36,272 | 321,386 | 606,500 | 138,000 | 187,000 | 951,000 |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 91,500 | -70,000 | -39,000 | -47,000 |
Operating Expenses | 46.7% | 12,787,491 | 8,715,985 | 11,195,421 | 11,364,249 | 9,564,698 | 13,539,658 | 8,258,461 | 5,399,102 | 4,775,449 | 6,304,199 | 44,838,479 | 4,959,631 | 6,507,928 | 6,123,055 | 4,312,810 | 3,739,033 | -219,653 | 2,221,648 | 2,340,807 | 2,690,839 | - |
S&GA Expenses | 23.6% | 2,988,200 | 2,417,484 | 3,648,944 | 2,995,771 | 2,516,443 | 2,386,461 | 2,551,171 | 2,208,800 | 1,299,935 | 1,890,492 | 5,659,721 | 1,669,807 | 2,564,508 | 3,049,711 | 3,114,495 | 1,995,536 | 1,565,992 | 1,046,524 | 1,973,256 | 1,561,106 | - |
R&D Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 2,598,985 | 3,943,420 | 3,073,344 | 1,198,315 | 1,743,497 | -1,785,645 | 1,175,124 | 367,551 | 1,129,733 | 1,335,503 |
EBITDA Margin | 40.4% | -114 | -191 | -529 | -1,654 | -2,255 | -1,952 | -1,044 | -2,010 | -696 | -741 | -419 | -142 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -11.2% | 752,820 | 847,341 | - | 304 | - | 1,970 | 1,154 | 44,064 | 335,498 | 2,118,433 | 1,019,307 | 572,985 | 472,052 | 431,626 | 427,245 | 558,292 | 1,038,014 | 154,656 | 110,508 | 99,483 | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -48.3% | -13,868,457 | -9,354,671 | -11,130,102 | -11,351,739 | -9,554,980 | -13,540,231 | -8,253,110 | -5,431,079 | -4,962,615 | -8,333,337 | -44,597,536 | -3,603,001 | -9,221,232 | -4,488,240 | -4,434,765 | -4,211,053 | -775,930 | -2,376,304 | -2,451,315 | -2,790,322 | - |
EBT Margin | 37.0% | -123 | -196 | -529 | -1,654 | -2,258 | -1,976 | -1,151 | -2,128 | -745 | -793 | -436 | -154 | - | - | - | - | - | - | - | - | - |
Net Income | -48.3% | -13,868,457 | -9,354,671 | -11,130,102 | -11,351,739 | -9,554,980 | -13,540,231 | -8,253,110 | -5,431,079 | -4,962,615 | -8,333,337 | -44,597,536 | -3,603,001 | -9,221,232 | -4,488,240 | -4,434,765 | -4,211,053 | -775,930 | -2,376,304 | -2,451,315 | -2,790,322 | - |
Net Income Margin | 37.0% | -123 | -196 | -529 | -1,654 | -2,258 | -1,976 | -1,151 | -2,128 | -745 | -793 | -436 | -154 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 2.2% | -9,749,676 | -9,969,952 | -7,786,324 | -9,751,173 | -7,973,295 | -8,176,743 | -7,110,701 | -6,230,012 | -6,418,495 | -4,161,335 | -6,200,114 | -2,632,385 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Assets | -71.9% | 9.00 | 33.00 | 42.00 | 32.00 | 39.00 | 50.00 | 57.00 | 66.00 | 40.00 | 39.00 | 14.00 | 15.00 | 3.00 | 5.00 | 10.00 | 15.00 | 13.00 | 6.00 | 9.00 | 11.00 | 13.00 |
Current Assets | -72.1% | 9.00 | 33.00 | 18.00 | 31.00 | 39.00 | 50.00 | 56.00 | 66.00 | 40.00 | 39.00 | 14.00 | 15.00 | 3.00 | 5.00 | 10.00 | 15.00 | 12.00 | 6.00 | 9.00 | 11.00 | 13.00 |
Cash Equivalents | -45.1% | 7.00 | 13.00 | 16.00 | 29.00 | 37.00 | 47.00 | 54.00 | 64.00 | 38.00 | 38.00 | 12.00 | 13.00 | 3.00 | 5.00 | 9.00 | 13.00 | 11.00 | 6.00 | 8.00 | 11.00 | 13.00 |
Net PPE | -12.8% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | -49.2% | 16.00 | 31.00 | 29.00 | 9.00 | 8.00 | 9.00 | 7.00 | 7.00 | 6.00 | 7.00 | 10.00 | 12.00 | 13.00 | 15.00 | - | 10.00 | 11.00 | 10.00 | - | - | - |
Current Liabilities | -49.3% | 16.00 | 31.00 | 13.00 | 9.00 | 8.00 | 8.00 | 7.00 | 7.00 | 6.00 | 7.00 | 10.00 | 12.00 | 16.00 | 15.00 | 13.00 | 10.00 | 11.00 | 10.00 | 8.00 | 7.00 | 5.00 |
Shareholder's Equity | -100.0% | - | 2.00 | 13.00 | 22.00 | 31.00 | 42.00 | 49.00 | 59.00 | 34.00 | 32.00 | 4.00 | 3.00 | - | - | - | 5.00 | 2.00 | - | 0.00 | 3.00 | 8.00 |
Retained Earnings | -6.5% | -226 | -212 | -200 | -191 | -180 | -168 | -159 | -145 | -137 | -132 | -127 | -118 | -74.17 | -70.56 | -61.66 | -52.44 | -47.95 | -43.52 | -39.30 | -38.53 | -34.31 |
Additional Paid-In Capital | 2.4% | 220 | 215 | 214 | 213 | 211 | 210 | 209 | 205 | 172 | 164 | 131 | 122 | 62.00 | 61.00 | 58.00 | 57.00 | 50.00 | 40.00 | 40.00 | 42.00 | 42.00 |
Shares Outstanding | 10.0% | 14.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 12.00 | 12.00 | 11.00 | 10.00 | 7.00 | 3.00 | 2.00 | 2.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 67.00 | - | - | - | 275 | - | - | - | 62.00 | - | - | - | 40.00 | - | - | - | 313 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Cashflow From Operations | -0.1% | -9,749 | -9,738 | -9,969 | -7,786 | -9,748 | -7,970 | -8,173 | -7,108 | -6,225 | -6,418 | -4,161 | -6,197 | -2,632 | -3,223 | -3,988 | -6,517 | -4,237 | -2,408 | -3,479 | -2,313 | -6,967 |
Share Based Compensation | -0.9% | 737 | 744 | 730 | 1,774 | 690 | 529 | 525 | 937 | 422 | 224 | 202 | 4,021 | 276 | 593 | 900 | 852 | 526 | -54.00 | -3,131 | -184 | 7,174 |
Cashflow From Investing | - | - | - | - | - | -2.84 | -2.63 | -2,421 | -1.88 | -5.01 | - | - | -3,187 | - | -2.46 | - | -9.47 | - | -75.00 | - | - | 61.00 |
Cashflow From Financing | -Infinity% | -12,285 | - | 19,912 | - | - | 1,358 | 180 | 32,638 | 6,875 | 31,834 | 3,124 | 20,190 | 707 | -1,044 | -485 | 8,370 | 10,004 | 101 | 928 | - | 19,528 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) | 3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2023 USD ($) $ / shares shares | Mar. 31, 2022 USD ($) $ / shares shares | |||
Operating expenses: | ||||
Research and development | $ 9,799,291 | $ 8,368,478 | ||
General and administrative | 2,988,200 | 2,995,771 | ||
Total operating expenses | 12,787,491 | 11,364,249 | ||
Loss from operations | (12,787,491) | (11,364,249) | ||
Other income (expense): | ||||
Interest income, net | 164,787 | 12,814 | ||
Interest expense | (752,820) | (304) | ||
Loss on extinguishment of convertible note payable | (414,291) | 0 | ||
Change in fair value of derivative liability | (78,642) | 0 | ||
Total other income (expense), net | (1,080,966) | 12,510 | ||
Loss before income taxes | (13,868,457) | (11,351,739) | ||
Income tax benefit | 0 | 0 | ||
Net loss | $ (13,868,457) | $ (11,351,739) | ||
Net loss per common share, basic (in dollars per share) | $ / shares | [1] | $ (1.02) | $ (0.88) | |
Net loss per common share, diluted (in dollars per share) | $ / shares | [1] | $ (1.02) | $ (0.88) | |
Weighted-average common shares, basic (in shares) | shares | [1] | 13,591,912 | 12,911,776 | |
Weighted-average common shares, diluted (in shares) | shares | [1] | 13,591,912 | 12,911,776 | |
|
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 6,938,991 | $ 12,646,282 |
Prepaid expenses and other current assets | 1,573,725 | 3,358,917 |
Restricted cash | 684,587 | 17,012,650 |
Total current assets | 9,197,303 | 33,017,849 |
Property and equipment, net | 9,084 | 10,413 |
Right-of-use asset | 97,670 | 112,302 |
Other assets | 8,980 | 7,280 |
Total assets | 9,313,037 | 33,147,844 |
Current liabilities: | ||
Accounts payable | 4,231,034 | 5,053,073 |
Accrued expenses | 5,757,675 | 4,379,773 |
Convertible note payable, net | 5,071,143 | 19,616,313 |
Derivative liability | 454,000 | 1,585,000 |
Lease liability, current portion | 63,617 | 61,746 |
Total current liabilities | 15,577,469 | 30,695,905 |
Lease liability, net of current portion | 34,773 | 51,396 |
Total liabilities | 15,612,242 | 30,747,301 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity (deficit): | ||
Preferred stock $0.0001 par value per share, 10,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2023 (unaudited) and December 31, 2022 | 0 | 0 |
Common stock $0.0001 par value per share, 550,000,000 shares authorized as of March 31, 2023 (unaudited) and December 31, 2022; 14,336,356 and 13,036,356 shares issued and outstanding as of March 31, 2023 (unaudited) and December 31, 2022, respectively | 1,434 | 1,304 |
Additional paid-in capital | 220,174,900 | 215,006,321 |
Accumulated deficit | (226,475,539) | (212,607,082) |
Total stockholders’ equity (deficit) | (6,299,205) | 2,400,543 |
Total liabilities and stockholders’ equity (deficit) | $ 9,313,037 | $ 33,147,844 |